与奥西默蒂尼布相关的肌肉毒性:FDA不良事件报告系统的不成比例分析

Yaqian Tan1,2, Qi Song3

  • 1Department of Pharmacy, The Affiliated Brain Hospital, Guangzhou Medical University, Mingxin Road 36, Liwan District, Guangzhou, 510370, China. tanyaqian2013@163.com.

BMC cancer
|August 22, 2025
PubMed
概括

这项研究使用现实数据研究了与奥西默蒂尼布相关的肌肉毒性. 增加的肌酸酶,肌炎和肌病被确定为显著的风险信号,为药物安全提供了洞察力.